Compositions and methods of treating retinal disease
US9650342B2 · kind B2 · utility
26Cited by
8References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 22, 2016 |
| Grant date | May 16, 2017 |
| Priority date | — |
| Expiry date | Feb 22, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.